Elisabetta Bugianesi mainly focuses on Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Fatty liver and Endocrinology. Her study in Insulin resistance, Cirrhosis, Liver disease, Metabolic syndrome and Liver biopsy is done as part of Internal medicine. Her Nonalcoholic fatty liver disease research incorporates elements of Steatosis, Liver transplantation, Hepatology, Fibrosis and Type 2 diabetes.
Her work carried out in the field of Gastroenterology brings together such families of science as Odds ratio, Hepatitis B, Surgery and Risk factor. Her research investigates the connection between Fatty liver and topics such as Liver function that intersect with problems in Family history and Homeostatic model assessment. Elisabetta Bugianesi focuses mostly in the field of Endocrinology, narrowing it down to matters related to Biopsy and, in some cases, Single-nucleotide polymorphism.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Fatty liver, Endocrinology and Nonalcoholic fatty liver disease. Her study on Insulin resistance, Cirrhosis, Non alcoholic and Fibrosis is often connected to In patient as part of broader study in Internal medicine. Her Insulin resistance study integrates concerns from other disciplines, such as Phlebotomy, Chronic hepatitis and Metabolic syndrome.
Elisabetta Bugianesi has included themes like Diabetes mellitus, Hepatocellular carcinoma and Liver biopsy in her Gastroenterology study. The study incorporates disciplines such as Steatosis, Type 2 diabetes and Cohort in addition to Fatty liver. Her Nonalcoholic fatty liver disease research is multidisciplinary, relying on both Liver disease and Obesity.
Internal medicine, Gastroenterology, Fatty liver, Disease and Non alcoholic are her primary areas of study. In general Internal medicine, her work in Fibrosis, Nonalcoholic fatty liver disease, Chronic liver disease and Cirrhosis is often linked to In patient linking many areas of study. Her Nonalcoholic fatty liver disease research incorporates themes from Liver disease, Gut flora and Obesity.
Her study in Gastroenterology is interdisciplinary in nature, drawing from both Hepatocellular carcinoma, Biopsy and Hazard ratio. Her Fatty liver research includes elements of Steatosis, Endocrinology, Transient elastography and Cohort. Her study in Insulin resistance and Insulin falls under the purview of Endocrinology.
Her primary scientific interests are in Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Steatohepatitis and Fatty liver. Her research combines Endocrinology and Internal medicine. Her research integrates issues of Diabetes mellitus, Gut flora and Obesity in her study of Nonalcoholic fatty liver disease.
Her Gastroenterology research includes themes of Crohn's disease and Hepatocellular carcinoma. Her Steatohepatitis study combines topics from a wide range of disciplines, such as Cirrhosis, Socioeconomic status, Public health and Cancer research. The various areas that Elisabetta Bugianesi examines in her Fatty liver study include Steatosis, Protein kinase B, Oncostatin M, National Health and Nutrition Examination Survey and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
Giulio Marchesini;Elisabetta Bugianesi;Gabriele Forlani;Fernanda Cerrelli.
Nonalcoholic fatty liver disease a feature of the metabolic syndrome
Giulio Marchesini;Mara Brizi;Giampaolo Bianchi;Sara Tomassetti.
Association of nonalcoholic fatty liver disease with insulin resistance
Giulio Marchesini;Mara Brizi;Antonio M Morselli-Labate;Giampaolo Bianchi.
The American Journal of Medicine (1999)
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini.
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi;Quentin M Anstee;Quentin M Anstee;Milena Marietti;Timothy Hardy;Timothy Hardy.
Nature Reviews Gastroenterology & Hepatology (2018)
Insulin resistance: A metabolic pathway to chronic liver disease†
Elisabetta Bugianesi;Arthur J. McCullough;Giulio Marchesini.
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
Elisabetta Bugianesi;Elena Gentilcore;Rita Manini;Stefania Natale.
The American Journal of Gastroenterology (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E. Bugianesi;A. Gastaldelli;E. Vanni;R. Gambino.
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
Nicola Villanova;Simona Moscatiello;Stefano Ramilli;Elisabetta Bugianesi.
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Anna Ludovica Fracanzani;Luca Valenti;Elisabetta Bugianesi;Marco Andreoletti.
Journal of Hepatology
(Impact Factor: 30.083)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: